Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations
2024 · Nature Medicine · 177 citations
https://doi.org/10.1038/s41591-024-02796-z
O
Ozan Dikilitas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
2.8K
Citations
25
h-index
38
i10-index
Ozan Dikilitas is an academic researcher from Mayo Clinic in Arizona. The author has contributed to research in topics: Genetic Associations and Epidemiology & Lipoproteins and Cardiovascular Health & BRCA gene mutations in cancer. The author has an h-index of 25, co-authored 91 publications.
ORCID: 0000-0002-9906-8608Papers by this author
worksDevelopment and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations
2022 · Genome Medicine · 159 citations
https://doi.org/10.1186/s13073-022-01074-2
Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure
2022 · Nature Communications · 137 citations
https://doi.org/10.1038/s41467-022-34216-6
Genome-wide association meta-analysis identifies risk loci for abdominal aortic aneurysm and highlights PCSK9 as a therapeutic target
2023 · Nature Genetics · 86 citations
https://doi.org/10.1038/s41588-023-01510-y
Genetic basis of hypercholesterolemia in adults
2021 · npj Genomic Medicine · 40 citations
https://doi.org/10.1038/s41525-021-00190-z
Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen
2021 · Journal of Lipid Research · 22 citations
https://doi.org/10.1016/j.jlr.2021.100160
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat